BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22320986)

  • 1. Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.
    Hosono S; Matsuo K; Ito H; Watanabe M; Hirose K; Nakanishi T; Tajima K; Tanaka H
    Asian Pac J Cancer Prev; 2011; 12(10):2747-52. PubMed ID: 22320986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
    Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CYP19A1 polymorphisms and sex hormones in postmenopausal Japanese women.
    Kidokoro K; Ino K; Hirose K; Kajiyama H; Hosono S; Suzuki T; Kawase T; Hiraki A; Hamajima N; Tanaka H; Tajima K; Kikkawa F; Matsuo K
    J Hum Genet; 2009 Feb; 54(2):78-85. PubMed ID: 19158807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese women.
    Hosono S; Ito H; Oze I; Higaki Y; Morita E; Takashima N; Suzuki S; Shimatani K; Mikami H; Ohnaka K; Ozaki E; Katsuura-Kamano S; Kubo M; Nagata C; Naito M; Hamajima N; Tanaka H;
    Maturitas; 2015 Dec; 82(4):394-401. PubMed ID: 26323233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.
    Xu WH; Dai Q; Xiang YB; Long JR; Ruan ZX; Cheng JR; Zheng W; Shu XO
    Am J Epidemiol; 2007 Dec; 166(12):1420-30. PubMed ID: 17827443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP19 (aromatase) haplotypes and endometrial cancer risk.
    Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
    Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
    Cai Q; Kataoka N; Li C; Wen W; Smith JR; Gao YT; Shu XO; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):27-32. PubMed ID: 18199708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
    Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
    Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
    BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
    Haiman CA; Dossus L; Setiawan VW; Stram DO; Dunning AM; Thomas G; Thun MJ; Albanes D; Altshuler D; Ardanaz E; Boeing H; Buring J; Burtt N; Calle EE; Chanock S; Clavel-Chapelon F; Colditz GA; Cox DG; Feigelson HS; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn JN; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Lenner P; Lund E; Panico S; Peeters PH; Pike MC; Riboli E; Tjonneland A; Travis R; Trichopoulos D; Wacholder S; Ziegler RG
    Cancer Res; 2007 Mar; 67(5):1893-7. PubMed ID: 17325027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
    Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.
    Cai H; Shu XO; Egan KM; Cai Q; Long JR; Gao YT; Zheng W
    Pharmacogenet Genomics; 2008 Aug; 18(8):657-64. PubMed ID: 18622258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
    Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in base excision repair genes are associated with endometrial cancer risk among postmenopausal Japanese women.
    Hosono S; Matsuo K; Ito H; Oze I; Hirose K; Watanabe M; Nakanishi T; Tajima K; Tanaka H
    Int J Gynecol Cancer; 2013 Nov; 23(9):1561-8. PubMed ID: 24172093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants.
    Ramirez-Lorca R; Grilo A; Martinez-Larrad MT; Manzano L; Serrano-Hernando FJ; Moron FJ; Perez-Gonzalez V; Gonzalez-Sanchez JL; Fresneda J; Fernandez-Parrilla R; Moñux G; Molero E; Sanchez E; Martinez-Calatrava MJ; Saban-Ruiz J; Ruiz A; Saez ME; Serrano-Rios M
    Hypertension; 2007 Nov; 50(5):884-90. PubMed ID: 17893373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women.
    Xu WH; Shrubsole MJ; Xiang YB; Cai Q; Zhao GM; Ruan ZX; Cheng JR; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):281-7. PubMed ID: 17301261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP19A1 genetic polymorphisms may be associated with obesity-related phenotypes in Chinese women.
    Long JR; Shu XO; Cai Q; Wen W; Kataoka N; Gao YT; Zheng W
    Int J Obes (Lond); 2007 Mar; 31(3):418-23. PubMed ID: 16894362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.
    Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1515-20. PubMed ID: 15342454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association between common polymorphisms in the aromatase gene CYP19A1 and bone mineral density in postmenopausal women.
    Mullin BH; Carter KW; Lewis JR; Ingley E; Wilson SG; Prince RL
    Calcif Tissue Int; 2011 Dec; 89(6):464-71. PubMed ID: 21952832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer.
    Razavi P; Lee E; Bernstein L; Van Den Berg D; Horn-Ross PL; Ursin G
    Int J Cancer; 2012 Apr; 130(7):1629-38. PubMed ID: 21544810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.